Physician

Anil Potti, MD

According to 2025 Medicare claims, Anil Potti, MD (NPI: 1427122266) practices hematology/oncology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is WILLIAM NOYES, MD PC (NPI: 1245332311; TIN: 201200995) and primary practice location at 58201-3434. Potti is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Potti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 632 traditional Medicare patients, billed 701,969 HCPCS/CPT codes, and received $9,940,893 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 875 prescription claims across 190 beneficiaries totaling $1,807,886 in drug costs, led by Verzenio (Abemaciclib). DME data shows 85 claims. Open Payments data shows 50 records totaling $982. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,165,826 to $9,940,893. Similarly, Part D prescription costs have risen steadily, from $671,580 to $1,807,886. In contrast, DME billing represents a smaller volume and rose steadily, from $1,935 to $4,249.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	301	339,767	$2,165,826
2016	340	419,337	$2,745,420
2017	442	633,570	$5,336,118
2018	500	721,143	$7,313,158
2019	558	849,635	$7,858,399
2020	542	763,819	$8,743,246
2021	568	815,753	$9,529,497
2022	560	897,826	$9,887,524
2023	592	764,465	$9,051,856
2024	632	701,969	$9,940,893

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	493	$671,580
2016	89	475	$806,899
2017	129	740	$715,063
2018	122	757	$465,212
2019	128	714	$893,332
2020	117	725	$1,067,802
2021	129	773	$1,064,808
2022	143	906	$1,353,335
2023	163	847	$1,136,073
2024	190	875	$1,807,886

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	26	$3,468
2016	N/R	61	$10,619
2017	N/R	41	$1,316
2018	N/R	70	$3,372
2019	N/R	27	$2,059
2020	N/R	19	$2,068
2021	N/R	24	$1,985
2022	N/R	19	$1,993
2023	N/R	104	$14,606
2024	N/R	85	$4,860

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	460	2,719	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	343	838	$69
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	254	978	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	328	908	$13
96372	Injection of drug or substance under skin or into muscle	272	2,203	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	19	532	$288,424
Lynparza	Olaparib	16	480	$260,267
Calquence	Acalabrutinib Maleate	12	360	$184,233
Eliquis	Apixaban	15	720	$12,865
Anastrozole	Anastrozole	133	6,905	$1,860

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	37	$3,646
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$585
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$339
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	17	$289

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$982	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anil Potti, MD?

Tedicare shows public-source Medicare data for Anil Potti, MD (NPI 1427122266), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil Potti, MD have ACO affiliation data?

Anil Potti, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Anil Potti, MD?

Anil Potti, MD is linked to WILLIAM NOYES, MD PC (billing NPI 1245332311) in the available physician profile data.

Does Anil Potti, MD have Open Payments data?

Anil Potti, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.